News

Nagma Zerin, lecturer in the Department of Chemical and Biomolecular Engineering, was named the William R. Kenan, Jr. Scholar/Teacher, effective Jan. 1, 2024. “(Zerin) has an interest in pedagogical research areas,…

Paulette Clancy, professor and former department head of the Whiting School of Engineering’s Department of Chemical and Biomolecular Engineering, and director of research (discovery and inquiry) for Johns Hopkins AI-X…

Jeffrey Gray, professor in the Department of Chemical and Biomolecular Engineering, was elected to the Board of Directors of the Open Molecular Software Foundation (OMSF). The foundation works to advance…

Nagma Zerin, lecturer in the Department of Chemical and Biomolecular Engineering, hosted a seminar on Oct. 27 featuring Jean Tom, executive director of development engineering and chemistry process development at…

The recipient of the 2023 William H. Walker Award is Ioannis (Yannis) Kevrekidis, the Bloomberg Distinguished Professor in the departments of Chemical and Biomolecular Engineering and Applied Mathematics and Statistics…

The award supports creative and innovative lines of research by early career scientists

Jude Phillip, assistant professor in the Department of Biomedical Engineering with a secondary appointment in the Department of Chemical and Biomolecular Engineering amd core researcher at the Institute for NanoBioTechnology and…

A joint project between the Whiting School, the University of Alabama, and the Oak Ridge National Laboratory aims to make the airline industry more sustainable through plant-based jet fuel

Johns Hopkins engineers will join a national research project to rapidly develop sense-and-respond implant technology that could slash U.S. cancer-related deaths by more than 50%. The $45 million award to 10 teams…

A new injectable solution that self-assembles into a gel under the right conditions could, under the right conditions, help manage HIV unlike any currently available methods, Johns Hopkins researchers have found

Technology developed by Johns Hopkins engineers could eventually treat an aggressive type of breast cancer